Sort
39,280 grants matching “leukemia”
Harnessing the thymus for long-term tumor control with hematopoietic stem cell-derived naive CAR T cells
$526,721Johannes Zakrzewski · Hackensack University Medical Center · R37 · FY2024 · CA
HTS for Synergistic Activators of Latent HIV-1 Infection
$526,579Olaf Kutsch · University Of Alabama At Birmingham · R01 · FY2015 · AI
HTS for Synergistic Activators of Latent HIV-1 Infection
$526,579Olaf Kutsch · University Of Alabama At Birmingham · R01 · FY2014 · AI
GEARBOx - a multisite clinical trial matching tool for children with relapsed or refractory cancer
$526,491Samuel Volchenboum · University Of Chicago · U01 · FY2023 · CA
Pharmacogenomics of Microtubule Targeting Agents
$526,471Deanna L Kroetz · University Of California, San Francisco · R01 · FY2019 · CA
MLL FUSION GENES IN MYELOID AND LYMPHOID LEUKEMIAS
$526,079Scott A Armstrong · Dana-Farber Cancer Inst · P01 · FY2009 · CA
The role of chromatin structure in differentiation of hematopoietic stem cells
$526,059Bruno Calabretta · Thomas Jefferson University · R01 · FY2019 · HL
The role of chromatin structure in differentiation of hematopoietic stem cells
$526,059Bruno Calabretta · Thomas Jefferson University · R01 · FY2017 · HL
The role of chromatin structure in differentiation of hematopoietic stem cells
$526,059Bruno Calabretta · Thomas Jefferson University · R01 · FY2016 · HL
Spermatogonial Stem Cell Self-Renewal and Differentiation
$526,050Robert E Braun · University Of Washington · U54 · FY2009 · HD
Severe Chronic Neutropenia International Registry
$525,902David Chandler Dale · University Of Washington · R24 · FY2013 · AI
Health Promotion in Minority Childhood Cancer Survivors
$525,632Melinda R Stolley · University Of Illinois At Chicago · R01 · FY2007 · CA
Targeting cancer stem cells in JAK2V617F induced neoplasm
$525,580Shaoguang Li · Univ Of Massachusetts Med Sch Worcester · R01 · FY2023 · CA
Targeting cancer stem cells in JAK2V617F induced neoplasm
$525,580Shaoguang Li · Univ Of Massachusetts Med Sch Worcester · R01 · FY2022 · CA
BCR-ABL Kinase Assays for STI571 Sensitivity of Response
$525,569Stephen J. Kron · University Of Chicago · R33 · FY2006 · CA
GENETIC EPIDEMIOLOGY OF CHRONIC LYMPHOCYTIC LEUKEMIA
$525,551Nicola J Camp · University Of Utah · R01 · FY2015 · CA
Screening for Resistant Enteric Bacteria to Personalize Infection Prevention Strategies in Neutropenic Patients
$525,544Michael Joseph Satlin · Weill Medical Coll Of Cornell Univ · R01 · FY2021 · AI
Targeting RET in Lung Cancer
$525,531Pasi A Janne · Dana-Farber Cancer Inst · R01 · FY2014 · CA
New control of oncogene activation in T-cell leukemia
$525,427Chengyu Liang · Wistar Institute · R01 · FY2025 · CA
Next-generation genetic engineering of the pan-leukocyte antigen CD45 to facilitate CAR-T cell therapy against hematologic malignancies
$525,419Saar Gill · University Of Pennsylvania · P01 · FY2025 · CA
Mechanisms by which Oncogene Inactivation Elicits Tumor Cell Death
$525,337Dean W Felsher · Stanford University · R01 · FY2015 · CA
Gvl mHA Specific T Cell Responses Prevent AML Relapse Following Allogeneic Stem Cell Transplantation
$525,246Benjamin G Vincent · Univ Of North Carolina Chapel Hill · R37 · FY2020 · CA
Gvl mHA Specific T Cell Responses Prevent AML Relapse Following Allogeneic Stem Cell Transplantation
$525,246Benjamin G Vincent · Univ Of North Carolina Chapel Hill · R37 · FY2021 · CA
Gvl mHA Specific T Cell Responses Prevent AML Relapse Following Allogeneic Stem Cell Transplantation
$525,246Benjamin G Vincent · Univ Of North Carolina Chapel Hill · R37 · FY2022 · CA
Enhancer Driven Gene Regulation During Lymphocyte Development
$525,166Jane Amanda Skok · New York University School Of Medicine · R01 · FY2016 · GM